Search
for

    GlossaryFOXC2

    FOXC2 is a gene that encodes a protein involved in the development and function of various tissues, including the formation of blood vessels and the regulation of fat storage. Mutations in FOXC2 can lead to conditions like lymphedema-distichiasis syndrome, which is characterized by swelling due to fluid retention and the presence of extra eyelashes. This gene also plays a role in hair follicle development and can impact hair growth and health.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 187 results

    Community Join

    5 / 5 results

      community 6 month results on topical min, oral fin, and microneedling

      in Progress Pictures  703 upvotes 1 year ago
      A user (Majestic-Head3874) who has had successful hair regrowth with the combination of topical minoxidil, oral finasteride and microneedling treatments. People are asking for details about these treatments and Majestic-Head3874 is sharing the regimen they used.

      community Looks like a real cure to the root of baldness (DHT-induced senescence) was proven earlier this year

      in Research/Science  742 upvotes 1 year ago
      A study that outlines the full model for androgenic alopecia (AGA) which links DHT to cellular senescence in dermal papilla cells, and suggests black chokeberry as a source of cyanidin 3-O-arabinoside polyphenol with potential anti-oxidant properties that could reverse this process. The post encourages reaching out to experts in anti-aging and longevity to research treatments involving the polyphenol.

      community Verteporfin day 119 update – donor hair regeneration human trial

      in Research/Science  146 upvotes 1 year ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  448 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.